Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
Clinical trial NCT05053607 · RECRUITING
Trial details
- NCT number
- NCT05053607
- Sponsor
- Pack Health
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-17
- Primary completion
- 2025-08-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.